NHTC on Nasdaq
NATURAL HEALTH TRENDS CORP
Natural Health Trends Corp. is an international direct-selling and e-commerce company.4 From its latest annual report
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with EDUCATIONAL DEVELOPMENT CORP, HYDROFARM HOLDINGS GROUP, INC. or QUEST PATENT RESEARCH CORP, or pick any stock.
- TickerNHTC on Nasdaq2
- IndustryWholesale-Miscellaneous Nondurable Goods2
- HeadquartersRolling Hills Estates, United States2
- Incorporated inDE3
- Business address609 Deep Valley Drive, Suite 395, Rolling Hills Estates, Ca 902743
- Filer categoryNon-accelerated filer, Smaller reporting company3
- Legal formCorporation2
- LEI529900WSPRKOOD9HNF272
- StatusActive2
- LEI statusLapsed (not renewed)2
- Registered addressc/o THE CORPORATION TRUST COMPANY, CORPORATION TRUST CENTER 1209 ORANGE ST, 19801 Wilmington, United States2
- Registered withDivision of Corporations, Department of State, 39339252
See how the biggest companies compare on our leaderboards
Natural Health Trends Corp. is an international direct-selling and e-commerce company. Through our subsidiaries, we sell personal care, wellness, and “quality of life” products under the “NHT Global” brand. Our wholly-owned subsidiaries have an active physical presence in the following markets: the Americas, which consists of the United States, Canada, Cayman Islands, Mexico, Peru and Colombia; Greater China, which consists of Hong Kong, Taiwan and China; Southeast Asia, which consists of Malaysia and Singapore; South Korea; Japan; India; and Europe. We also operate in Russia and Kazakhstan through our engagement with a local service provider.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Product brought in 97% of the revenue NATURAL HEALTH TRENDS CORP broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Product | $41.7M | $39.0M |
| Administrative Fees, Freight and Other | $1.5M | $1.1M |
Business segments
Primary Reporting brought in 97% of the revenue NATURAL HEALTH TRENDS CORP broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Primary Reporting | $40.9M | $38.4M |
| China | $1.6M | $946.0K |
| Russia and Kazakhstan | $490.0K | $444.0K |
Regions
Hong Kong brought in 82% of the revenue NATURAL HEALTH TRENDS CORP broke down this way in fiscal 2025.
Regions by year
| Regions | 2024 | 2025 |
|---|---|---|
| Hong Kong | $35.1M | $32.7M |
| Taiwan | $1.6M | $1.5M |
| Peru and Colombia | $1.1M | $1.2M |
| United States | $1.0M | $1.2M |
| China | $1.6M | $946.0K |
| Europe | $635.0K | $530.0K |
| Other Foreign Countries | $589.0K | $477.0K |
| Canada | $535.0K | $475.0K |
| Russia and Kazakhstan | $490.0K | $444.0K |
| Japan | $292.0K | $333.0K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue26¢$10.5M
- Selling, general and admin37¢$14.8M
- Other costs36¢$14.2M
- Income tax1¢$315.0K
Out of $39.8M in revenue.5 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net sales | $39.8M | $43.0M |
| Cost of sales | $10.5M | $11.2M |
| Gross profit | $29.3M | $31.8M |
| Commissions expense | $16.3M | $17.6M |
| Selling, general and administrative expenses | $14.8M | $15.5M |
| Total operating expenses | $31.1M | $33.1M |
| Loss from operations | -$1.8M | -$1.3M |
| Other income, net | $1.2M | $1.9M |
| Income (loss) before income taxes | -$567.0K | $620.0K |
| Income tax provision | $315.0K | $48.0K |
| Net income (loss) | -$882.0K | $572.0K |
| Basic (in dollars per share) | -$0.08 | $0.05 |
| Diluted (in dollars per share) | -$0.08 | $0.05 |
| Basic (in shares) | 11.5M shares | 11.5M shares |
| Diluted (in shares) | 11.5M shares | 11.5M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 3 fiscal years (annual) or 3 quarters (quarterly), latest first.5
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $6.8M | $13.5M | |
| Marketable securities | $22.1M | $30.4M | |
| Inventories, net | $2.0M | $3.3M | |
| Other current assets | $3.3M | $3.8M | |
| Total current assets | $34.2M | $51.0M | |
| Property and equipment, net | $153.0K | $190.0K | |
| Operating lease right-of-use assets | $1.9M | $2.5M | |
| Restricted cash | $7.0K | $34.0K | |
| Deferred tax asset | $289.0K | $382.0K | |
| Other assets | $1.9M | $1.3M | |
| Total assets | $38.4M | $55.4M | |
| Accounts payable | $555.0K | $895.0K | |
| Income taxes payable | $5.0K | $4.9M | |
| Accrued commissions | $2.0M | $2.0M | |
| Other accrued expenses | $1.4M | $1.4M | |
| Deferred revenue | $5.6M | $6.4M | |
| Amounts held in eWallets | $2.8M | $3.3M | |
| Operating lease liabilities | $869.0K | $1.1M | |
| Other current liabilities | $451.0K | $709.0K | |
| Total current liabilities | $13.7M | $20.8M | |
| Deferred tax liability | $180.0K | $174.0K | |
| Operating lease liabilities | $1.1M | $1.5M | |
| Total liabilities | $15.0M | $22.5M | |
| Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding | $0 | $0 | |
| Common stock, $0.001 par value; 50,000,000 shares authorized; 12,979,414 shares issued at December 31, 2025 and 2024 | $13.0K | $13.0K | |
| Additional paid-in capital | $85.0M | $84.9M | |
| Accumulated deficit | -$36.4M | -$26.3M | |
| Accumulated other comprehensive loss | -$784.0K | -$1.3M | |
| Treasury stock, at cost; 1,466,339 shares at December 31, 2025 and 2024 | -$24.4M | -$24.4M | |
| Total stockholders equity | $23.4M | $32.9M | $41.6M |
| Total liabilities and stockholders equity | $38.4M | $55.4M | |
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Preferred stock, authorized (in shares) | 5.0M shares | 5.0M shares | |
| Preferred stock, issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, authorized (in shares) | 50.0M shares | 50.0M shares | |
| Common stock, issued (in shares) | 13.0M shares | 13.0M shares | |
| Treasury stock, shares (in shares) | 1.5B shares | 1.5B shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $6.8M | $13.5M | |
| Marketable securities | $22.1M | $30.4M | |
| Inventories, net | $2.0M | $3.3M | |
| Other current assets | $3.3M | $3.8M | |
| Total current assets | $34.2M | $51.0M | |
| Property and equipment, net | $153.0K | $190.0K | |
| Operating lease right-of-use assets | $1.9M | $2.5M | |
| Restricted cash | $7.0K | $34.0K | |
| Deferred tax asset | $289.0K | $382.0K | |
| Other assets | $1.9M | $1.3M | |
| Total assets | $38.4M | $55.4M | |
| Accounts payable | $555.0K | $895.0K | |
| Income taxes payable | $5.0K | $4.9M | |
| Accrued commissions | $2.0M | $2.0M | |
| Other accrued expenses | $1.4M | $1.4M | |
| Deferred revenue | $5.6M | $6.4M | |
| Amounts held in eWallets | $2.8M | $3.3M | |
| Operating lease liabilities | $869.0K | $1.1M | |
| Other current liabilities | $451.0K | $709.0K | |
| Total current liabilities | $13.7M | $20.8M | |
| Deferred tax liability | $180.0K | $174.0K | |
| Operating lease liabilities | $1.1M | $1.5M | |
| Total liabilities | $15.0M | $22.5M | |
| Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding | $0 | $0 | |
| Common stock, $0.001 par value; 50,000,000 shares authorized; 12,979,414 shares issued at December 31, 2025 and 2024 | $13.0K | $13.0K | |
| Additional paid-in capital | $85.0M | $84.9M | |
| Accumulated deficit | -$36.4M | -$26.3M | |
| Accumulated other comprehensive loss | -$784.0K | -$1.3M | |
| Treasury stock, at cost; 1,466,339 shares at December 31, 2025 and 2024 | -$24.4M | -$24.4M | |
| Total stockholders equity | $23.4M | $32.9M | $41.6M |
| Total liabilities and stockholders equity | $38.4M | $55.4M | |
| Preferred stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Preferred stock, authorized (in shares) | 5.0M shares | 5.0M shares | |
| Preferred stock, issued (in shares) | 0 shares | 0 shares | |
| Preferred stock, outstanding (in shares) | 0 shares | 0 shares | |
| Common stock, par value (in dollars per share) | $0.00 | $0.00 | |
| Common stock, authorized (in shares) | 50.0M shares | 50.0M shares | |
| Common stock, issued (in shares) | 13.0M shares | 13.0M shares | |
| Treasury stock, shares (in shares) | 1.5B shares | 1.5B shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.5
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net income (loss) | -$882.0K | $572.0K |
| Depreciation and amortization | $109.0K | $131.0K |
| Net accretion of marketable securities | -$375.0K | -$441.0K |
| Share-based compensation | $132.0K | $145.0K |
| Noncash lease expense | $1.1M | $1.1M |
| Deferred income taxes | $102.0K | $17.0K |
| Inventories | $1.3M | $1.0M |
| Other current assets | $1.2M | -$113.0K |
| Other assets | -$640.0K | -$421.0K |
| Accounts payable | -$341.0K | -$94.0K |
| Income taxes payable | -$4.9M | -$3.9M |
| Accrued commissions | -$111.0K | -$19.0K |
| Other accrued expenses | -$7.0K | $271.0K |
| Deferred revenue | -$854.0K | $245.0K |
| Amounts held in eWallets | -$445.0K | -$672.0K |
| Operating lease liabilities | -$1.1M | -$1.2M |
| Other current liabilities | -$279.0K | -$62.0K |
| Net cash used in operating activities | -$6.0M | -$3.4M |
| Purchases of property and equipment | -$68.0K | -$57.0K |
| Purchases of marketable securities | -$50.7M | -$70.4M |
| Proceeds from maturities of marketable securities | $59.0M | $40.4M |
| Net cash provided by (used in) investing activities | $8.1M | -$30.1M |
| Dividends paid | -$9.2M | -$9.2M |
| Net cash used in financing activities | -$9.2M | -$9.2M |
| Net decrease in cash, cash equivalents and restricted cash | -$6.7M | -$42.6M |
| Effect of exchange rates on cash, cash equivalents and restricted cash | $312.0K | $5.0K |
| Right-of-use assets obtained in exchange for operating lease liabilities | $487.0K | $124.0K |
No quarter-by-quarter statement was filed.
Leadership
Who has led NATURAL HEALTH TRENDS CORP, and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
Chief operating officer
- Chief executive officerRobert H. Hesse Mar 17, 2006 to Mar 17, 200613
- Chief executive officerStephanie S. Hayano Aug 8, 2006 to Aug 8, 200614
- PresidentJohn Francis Cavanaugh Feb 1, 2007 to Sep 18, 200815
- PresidentCurtis E. Broome Mar 1, 2007 to Jan 3, 200816
- PresidentChris Tahjiun Sharng Apr 24, 2007 to now17
- PresidentStephanie S. Hayano Aug 8, 2006 to Aug 8, 200614
- Chief financial officerTimothy Scott Davidson Apr 24, 2007 to now18
- Chief financial officerChris Tahjiun Sharng Aug 25, 2006 to Feb 13, 200719
- Chief operating officerGernot Senke Feb 13, 2007 to Feb 13, 200720
Board members and other officers (17)
- Chief Accounting OfficerTimothy Scott Davidson Feb 13, 2007 to Feb 13, 200721
- Board memberEllen Sun Jun 8, 2026 to now22
- Board memberLucy Njeri Nduati Aug 7, 2024 to now23
- Board memberBrunde E. Broady May 18, 2021 to Dec 16, 202224
- Board memberChing Chung Wong Jun 4, 2020 to now25
- Board memberChris Tahjiun Sharng Jan 22, 2015 to now26
- Board memberKin Yep Chung Feb 17, 2015 to Jun 4, 202027
- Board memberYiu Tung Chan Dec 16, 2015 to now28
- Board memberGeorge K. Broady Oct 27, 2008 to Dec 27, 202129
- Board memberAnthony B. Martino Feb 2, 2007 to Jul 25, 200730
- Board memberTerrence M. Morris Feb 2, 2007 to Feb 13, 200731
- Board memberBrian Wolfson Sir. Feb 13, 2007 to Apr 24, 200732
- Board memberRandall A. Mason Feb 13, 2007 to now33
- Board memberStefan Zuckut Jun 6, 2007 to Jul 2, 200934
- Board memberRobert H. Hesse Mar 17, 2006 to Mar 17, 200613
- Board memberStephanie S. Hayano Aug 8, 2006 to Aug 8, 200614
- Board memberBrien Colin O. Aug 21, 2006 to Nov 27, 200635
Timeline
Filings
143 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 34 major events, 70 insider forms, 5 large holders, 1 private raises, 13 other. The latest 20:
- Jul 29, 202610-Q EDGAR
- Jul 29, 20268-K EDGAR
- Jun 8, 20263 EDGAR
- May 7, 20268-K EDGAR
- Apr 29, 202610-Q EDGAR
- Apr 29, 20268-K EDGAR
- Mar 30, 2026ARS EDGAR
- Mar 24, 2026DEFA14A EDGAR
- Mar 24, 2026DEF 14A EDGAR
- Mar 24, 2026DEF 14A EDGAR
- Feb 20, 202610-K EDGAR
- Feb 18, 2026SCHEDULE 13D EDGAR
- Feb 17, 20268-K EDGAR
- Feb 4, 20268-K EDGAR
- Nov 5, 202510-Q EDGAR
- Nov 5, 20258-K EDGAR
- Jul 30, 202510-Q EDGAR
- Jul 30, 20258-K EDGAR
- May 6, 20258-K EDGAR
- Apr 30, 202510-Q EDGAR
The 143 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Chris Tahjiun SharngSCHEDULE 13D, 2 filings Apr 16, 2024 to Feb 18, 202636
- RENAISSANCE TECHNOLOGIES LLCSC 13G/A, 3 filings Feb 11, 2022 to Feb 13, 202437
Money raised
Private offerings the company reported to the SEC on Form D.
- Feb 6, 2023Raised $42,592 in a private offering of equity Form D: 4 investors so far Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARJohn Francis Cavanaugh, President
- 16SEC EDGARCurtis E. Broome, President
- 17SEC EDGARChris Tahjiun Sharng, President
- 18
- 19
- 20
- 21
- 22SEC EDGAREllen Sun, Board member
- 23SEC EDGARLucy Njeri Nduati, Board member
- 24SEC EDGARBrunde E. Broady, Board member
- 25SEC EDGARChing Chung Wong, Board member
- 26SEC EDGARChris Tahjiun Sharng, Board member
- 27SEC EDGARKin Yep Chung, Board member
- 28SEC EDGARYiu Tung Chan, Board member
- 29SEC EDGARGeorge K. Broady, Board member
- 30SEC EDGARAnthony B. Martino, Board member
- 31SEC EDGARTerrence M. Morris, Board member
- 32SEC EDGARBrian Wolfson Sir., Board member
- 33SEC EDGARRandall A. Mason, Board member
- 34SEC EDGARStefan Zuckut, Board member
- 35SEC EDGARBrien Colin O., Board member
- 36
- 37